March 19 (Reuters) - Dragonfly Therapeutics:
* DRAGONFLY THERAPEUTICS- ANNOUNCED EXPANSION OF STRATEGIC COLLABORATION WITH MERCK
* DRAGONFLY - COLLABORATION WITH MERCK TO USE CO'S PROPRIETARY TRINKET PLATFORM TO DEVELOP THERAPEUTIC CANDIDATES IN FIELDS OF ONCOLOGY, INFECTIOUS DISEASE
* DRAGONFLY - MERCK WILL PAY DRAGONFLY APPROXIMATELY $47.5 MILLION UPFRONT
* DRAGONFLY- ELIGIBLE TO GET ADDITIONAL PAYMENTS RELATED TO DEVELOPMENT, REGULATORY, SALES MILESTONES, POTENTIAL ROYALTIES ON SALES OF APPROVED PRODUCT